Astellas Pharma has unveiled encouraging preliminary results from OPTION-VMS, its ongoing phase 4 observational study evaluating fezolinetant in women...
Read MoreENA Respiratory has closed a US$22.4 million (AU$34 million) Series B round to propel its lead therapy, INNA-051, into...
Read MoreMr Whippy is stepping beyond soft-serve and into the sweet-treat big league with a £15 million manufacturing site in...
Read MoreEnterome has secured Fast Track designation from the US Food and Drug Administration (FDA) for EO2463, its lead OncoMimics®...
Read MoreAdocia and Tonghua Dongbao have announced positive topline results from a Phase 3 clinical trial of BioChaperone® Lispro (THDB0206...
Read MoreLancashire-based confectioner Stockley’s has completed a major expansion, moving into a new 60,000 sq ft facility in Burnley as...
Read More